Brendan will discuss his research on the innovation processes of Grand River Hospital, Kids Ability, and Schlegel Villages as well as provide an introduction to the concept of open-innovation, specifically in healthcare.
He will also provide an overview of a Workplace Innovation Program that uses a similar innovation management model to CREATE. As part of that program, they use a needs “Needs Finding and Assessment” process to help teams identify the most valuable and viable opportunities for new products and services.
COVID-19 has brought disease and mortality at levels not seen from a respiratory virus for over 100 years. Immune responses to this virus, which can infect several different tissues, are poorly understood, including the role of antibodies in resolving the infection. In March 2020, we reoriented our lab to develop Enzyme-Linked ImmunoSorbent Assays (ELISA) for human antibody isotypes IgM, IgG and IgA produced in response to the SARS-CoV-2 spike protein. To date we have analyzed samples from 114 patients, including both PCR positive and PCR negative individuals.
The Centre for Bioengineering and Biotechnology is pleased to present the innovative work of Professor Alexander Wong.